XML 20 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions - Additional Information (Detail) (USD $)
In Thousands, unless otherwise specified
6 Months Ended 6 Months Ended
Mar. 31, 2013
Cato [Member]
Mar. 11, 2013
Cato [Member]
Mar. 31, 2013
Cato [Member]
Medical [Member]
Mar. 31, 2013
Safety Syringes [Member]
Dec. 24, 2012
Safety Syringes [Member]
Mar. 31, 2013
Safety Syringes [Member]
Medical [Member]
Business Acquisition [Line Items]            
Percentage of outstanding shares acquired   100.00%     100.00%  
Acquisition-date fair value of consideration transferred net of in cash acquired $ 23,307 $ 23,307   $ 124,088 $ 124,088  
Cash acquired in acquisition   140     1,262  
Fair value of consideration transferred in cash   14,487     123,738  
Fair value of contingent consideration   8,820        
Developed technology 8,900     68,800    
Risk-adjusted discount rate 14.50%     16.00%    
Amortization of technology, expected useful life 15 years     15 years    
Goodwill 11,329   11,329 34,255   34,255
Portion of goodwill currently expected to be deductible for tax purposes 0     34,255    
Acquisition-related costs in the current period 650     1,980    
Fair value of consideration transferred for effective settlement of an intangible assets         350  
Gain/loss recognized on settlement         $ 0